key: cord-0719197-j88sg0gv
authors: Adler, Laurent; Lipton, Cathy; Watson, Clay C.; Lawrence, Shanieek; Richie, Alexa; Spain, Clare; Heltemes, Kevin
title: Mortality Reduction Associated with Coexistent Antithrombotic Use in Nursing Home Residents with COVID-19
date: 2021-11-19
journal: J Am Med Dir Assoc
DOI: 10.1016/j.jamda.2021.11.012
sha: 44deecc26c4a4e4234538aab394986aaaa70222b
doc_id: 719197
cord_uid: j88sg0gv

Nursing home residents have a high mortality when infected by COVID-19. This study identifies an association between use of antithrombotics and a reduction in 30-day mortality.

facility, SNF, nursing home, long-term care, mortality 6 7 8

To the Editor: 9 Long term care facilities, particularly skilled nursing facilities (SNFs), have felt the impact of the 10 COVID-19 pandemic, with high mortality rates observed in residents. SNF residents comprise 11 less than 1% of the US population 1 , however this population accounted for over 31% of COVID- J o u r n a l P r e -p r o o f 

Long-term care 82 providers and services users in the United States

The New York Times. Nearly One-Third of U.S. Coronavirus Deaths Are Linked to Nursing 85

Risk of venous thromboembolism in patients 88 with COVID-19: A systematic review and meta-analysis. Research and Practice in 89 Thrombosis and Haemostasis

Autopsy findings and Venous 92

Thromboembolism in Patients with COVID-19: A Prospective Cohort Study

Therapeutic anticoagulation with 95 heparin in noncritically ill patients with Covid-19

COVID-19 and VTE/Anticoagulation: Frequently Asked 98

Antithrombotic Therapy in Patients with COVID-19

AMDA -The Society for Post-Acute and Long-Term Care Medicine. Q & A Document for 104 COVID-19 Updated